Daktari Diagnostics, Inc. — Form D
Daktari Diagnostics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-08-26. The offering totals $3.0M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-08-26
- Form: D
- Accession: 0001470342-09-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $2.5M
- Remaining: $415K
- Investors: 39
- Date of first sale: 2009-08-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-133936
Issuer
- Name: Daktari Diagnostics, Inc.
- CIK: 0001470342
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 85 BOLTON STREET, CAMBRIDGE, MA, 02140
- Phone: 617-336-3299
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Stanley Lapidus | Director | BOSTON, MA |
| Roger Kitterman | Director | Boston, MA |
| Aaron Sandoski | Director | Bedford, MA |
| David Rubin | Director | Ann Arbor, MI |
| Michael Crowley | Executive Officer | Traverse City, MI |
| William Rodriguez | Director | Miami, FL |
| William Rodriguez | Executive Officer | Miami, FL |
| Thierry Bernard | Director | Bedford, MA |
| Edward Roberts | Director | Milford, NH |
| Peter Kaspar | Director | Cambridge, MA |
| Donald Hawthorne | Director | Cambridge, MA |
| Donald Hawthorne | Executive Officer | Cambridge, MA |
| Christopher Earl | Director | Cambridge, MA |
Other filings by this issuer (8)
More